MK3475-590:A Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial of Pembrolizumab (MK-3475) in Combination With Cisplatin and 5-Fluorouracil Versus Placebo in Combination With Cisplatin and 5-Fluorouracil as First-Line Treatment in Subjects With Advanced/Metastatic Esophageal Carcinoma (KEYNOTE-590)

February 17, 2019
https://clinicaltrials.gov/ct2/results?id=NCT03189719
Cancer - Esophageal
Principal Investigator: Rabbie K Hanna, MD
Cancer, Phase 3, Phase III, Esophageal, Esophageal Cancer, Esophageal neoplasms, esophagus, advanced, Metastatic, adenocarcinoma
Open